- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00916695
Everolimus-Eluting Stent for Bifurcation Coronary Lesions: Comparison of Simple Versus Complex Techniques
Everolimus-Eluting Stent in the Treatment of Bifurcation Lesions: Comparison of Main Vessel Stent to Main Vessel and Side Branch Stent
Study Overview
Status
Conditions
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Sevilla, Spain, 41007
- Recruiting
- Hospital Universitario Virgen Macarena
-
Contact:
- Rafael J Ruiz-Salmeron, PhD
- Phone Number: +34955693440
- Email: rjruizsalmeron@yahoo.es
-
Seville, Spain, 41007
- Not yet recruiting
- University Hospital Virgen Macarena
-
Contact:
- Rafael j Ruiz-Salmeron, PhD
- Phone Number: 0034955693449
- Email: rjruizsalmeron@yahoo.es
-
Principal Investigator:
- Rafael J Ruiz-Salmeron, Phd
-
Sub-Investigator:
- Manuel Vizcaino, PhD
-
Sub-Investigator:
- Sergio Rodriguez-Leiras, MD
-
Sub-Investigator:
- Cesar Carrascosa, MD
-
Sub-Investigator:
- Francisco Marcos, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients over 18 years old.
- True Bifurcation lesion (Medina classification 1-1-1), in at least one main coronary vessel. Diameter of main vessel between 2,5-4mm, and diameter of side branch 2mm or greater.
Exclusion Criteria:
- Significant left main stenosis.
- ST elevation myocardial infarction < 48 h.
- Thrombus burden target lesion.
- Ejection Fraction < 30%.
- Severe Renal Insufficiency (creatinine > 3 mg/dl).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Complex PCI strategy for bifurcation coronary lesions
Stenting main vessel and T-stenting for the side branch
|
Complex PCI strategy for bifurcation: After optional pre-dilation of one or both vessels (main and side branch), and subsequent implanting of the stent in the main vessel, the side branch is approached by implanting a new stent as T technique. Simple PCI strategy for bifurcation: After optional pre-dilation of one or both vessels (main and side branch), a stent is deployed at main vessel. Side branch is approached by using provisional T stenting technique. |
ACTIVE_COMPARATOR: Simple PCI strategies for bifurcation coronary lesions
Stenting main vessel, with provisional stenting for the side branch.
|
Complex PCI strategy for bifurcation: After optional pre-dilation of one or both vessels (main and side branch), and subsequent implanting of the stent in the main vessel, the side branch is approached by implanting a new stent as T technique. Simple PCI strategy for bifurcation: After optional pre-dilation of one or both vessels (main and side branch), a stent is deployed at main vessel. Side branch is approached by using provisional T stenting technique. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Comparison of the rate of binary angiographic restenosis (in main vessel and side branch) in the simple versus complex strategy groups
Time Frame: 9 months
|
9 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Combined rate of events (cardiac death, myocardial infarction and TLR)
Time Frame: 8 months
|
8 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Federico Gimeno, MD, Hospital Clínico Universitario Valladolid
- Principal Investigator: Bruno Garcia, MD, Hospital Valle de Hebron. Barcelona
- Principal Investigator: Ramiro Trillo, MD, Hospital Clínico Santiago
- Principal Investigator: Jose Moreu, MD, Hospital Virgen De La Salud
- Principal Investigator: Javier Goicolea, MD, Hospital Puerta de Hierro, Madrid
- Principal Investigator: Raul Moreno, MD, Hospital Universitario La Paz
- Principal Investigator: Jose F Diaz, MD, Hospital Juan Ramon Jimenez. Huelva
- Principal Investigator: Jose M Hernandez, MD, Hospital Clínico de Malaga
- Principal Investigator: Ramon Lopez-Palop, MD, Hospital San Juan. Alicante
- Principal Investigator: Mariano Valdes, MD, Hospital Universitario Virgen de La Arrixaca
- Principal Investigator: Pascual Bordes, MD, Hospital Universitario. Alicante
- Principal Investigator: Jose R Rumoroso, MD, Hospital Galdakao. Vizcaya
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- XV02RS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on Xience V Everolimus Eluting Coronary Stent System. Abbott Laboratories. Abbott Park, Illinois, U.S.A.
-
Medtronic VascularMedtronic Bakken Research CenterCompletedCoronary Artery DiseaseSwitzerland
-
Abbott Medical DevicesCompleted
-
University of Roma La SapienzaUnknownCoronary Artery DiseaseItaly
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary RestenosisIndia
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary RestenosisIreland, Netherlands, Singapore, Spain, China, Belgium, Switzerland, Thailand, Israel, Germany, New Zealand, United Kingdom, Italy, Malaysia, Canada, India, Austria, France, South Africa, Portugal, Czech Republic, Greece, Sweden
-
Yonsei UniversityGangwon Cardiovascular Health Research InstituteTerminated
-
Abbott Medical DevicesCompletedMyocardial Ischemia | Coronary Artery Disease | Stent Thrombosis | Vascular Disease | Coronary Artery Stenosis | Stents | Total Coronary Occlusion | Coronary Artery RestenosisUnited States
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary RestenosisNetherlands, Spain, Denmark, Germany, France, Austria, Belgium, India, Italy, New Zealand, Poland, South Africa, Switzerland
-
Abbott Medical DevicesCompletedCoronary Artery DiseaseUnited States
-
Flanders Medical Research ProgramCompletedPeripheral Vascular Disease | Critical Limb IschemiaBelgium, France, Germany